Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » Cell Line Development Using the Beacon® Platform

Cell Line Development Using the Beacon® Platform

Summary: Speed and efficiency are top priorities for companies looking to develop a clonal cell line for drug substance manufacturing.  Catalent was the first CDMO in North America to adopt the Berkeley Lights Beacon® platform for cell line development, leveraging the Beacon platform and Catalent’s GPEx® cell line development technology to accelerate timelines and increase productivity.

Click here to view the Case Study

Related Topics